ArticleCureus2025
Emerging and Re-emerging Pathogens Causing Blood Stream Infections (BSI) in Hospitalized Patients at a Tertiary Care Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives Infectious diseases known as bloodstream infections (BSIs) are characterized by the presence of live microorganisms in the bloodstream, which are subsequently confirmed by the positive results of one or more blood cultures. These conditions cause or have caused an inflammatory response, which is reflected in changes to hemodynamic, laboratory, and clinical parameters. In the current scenario, hospitalized patients are more likely to die from BSI caused by a number of emerging and re-emerging (E&Re) bacteria. Re-emerging means recurrence or new outbreaks of old infectious diseases with important public health relevance. It is difficult to identify these species using conventional identification methods. Automated techniques can be used for identification and testing for antibiotic susceptibility. The objective of this research is to ascertain the frequency of newly identified E&Re bacterial pathogens that cause BSIs, as well as their pattern of antibiotic susceptibility, risk factors, and post-BSI outcomes. Materials and methods This was a retrospective study, carried out over the course of two years (June 2022 to May 2024) at the Department of Microbiology, Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar. All the relevant data were collected from electronic records and entered into an Excel sheet for analysis. An identification/sensitivity testing system (VITEK 2, bioMérieux, Marcy-l'Étoile, France) and automated blood culture (BacT/Alert 3D, bioMérieux, Marcy-l'Étoile, France) were used to process the samples. Results In total, 5730 (18%) of the 31850 blood cultures showed positive microbial growth. Paired bottle culture, which came to be positive, was 2718 (47.43%). A total of 430 (15.82%) E&Re pathogens and 2288 (84.17%) common pathogens were isolated from the paired positive blood culture, showing their strong association with BSI. Out of the total E&Re pathogens, bacterial pathogens isolated were 363 (84.41%), and the fungal pathogen (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.